CVS Aetna Bid Sparks Talk of Lower Costs for Patients
CVS Health and Aetna merger talks could yield lower co pays and cheaper drugs if approved. Analysts say PBM integration might reduce drug costs, though skeptics warn savings may favor companies more than consumers. CVS Caremark would expand to broader health services amid regulatory scrutiny.
MENTIONED IN THIS ARTICLE
San Francisco
Aetna
CVS Health
The
Wall Street Journal
CVS Healthcare
CVS
CVS Caremark
PBM
Joseph Agnese
CFRA
Agnese
Mohamed Jalloh
American Pharmacists Association
Laurence Baker
Department of Health Research and Policy
Stanford University Medical School
Baker
UnitedHealth
Pharmacy
Adams Dudley
University of California, San Francisco
Dudley
Ucsf Cen
Aaron Katz
University of Washington
School of Public Health
Costco
Humana
Arbitration Rule Repeal Shifts to Consumer Bank Disputes
The Senate voted to kill a rule allowing class action lawsuits against banks and lenders, pushing disputes toward arbitration. President Trump signed the rollback, shaping outcomes for the CFPB and cases involving Wells Fargo and Equifax amid broader industry pushback and a consumer-friendly study of arbitration versus class actions.
MENTIONED IN THIS ARTICLE
Senate
Trump
Consumer Financial Protection Bureau
Bureau
Richard Cordray
Wells Fargo
Equifax
U.S. Chamber of Commerce
Consumer Bureau
The
American Bankers Association
Consumer Bankers Association
Financial Services Roundtable
H. Darr Beiser
USA Today
Also Mentioned on This Page
Pbms
Mat Rource
American Arbitration Association
USA
National Foundation For Credit Counseling
Jae Yang and
Paultrap